Vincent R. Anicetti, Chief Operating Officer at Coherus BioSciences, Inc. (CHRS), sold 38,757 shares at $17.68 ($686K) on 2020-11-17, disclosed to the SEC on 2020-11-19.
Open-market sale of $686k CHRS by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.50 | 2,500 | $44K | 6.4% |
| 2 | $17.68 | 3,567 | $63K | 9.2% |
| 3 | $17.68 | 3,567 | $63K | 9.2% |
| 4 | $17.68 | 12,420 | $220K | 32.0% |
| 5 | $17.68 | 12,420 | $220K | 32.0% |
| 6 | $18.00 | 4,283 |
| $77K |
| 11.2% |
| Total | $17.70 avg | 38,757 | $686K | 100% |
| Filing → |
| CHRS | SELL | 2021-01-21 | $45K | — | Filing → |
| CHRS | SELL | 2020-12-21 | $44K | — | Filing → |
| CHRS | SELL | 2020-12-09 | $324K | — | Filing → |